Welcome to our dedicated page for Axcelis Tech Ord news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Tech Ord stock.
The Axcelis Technologies Inc (ACLS) news page on Stock Titan aggregates company announcements, industry event participation and regulatory disclosures focused on its role in the semiconductor equipment market. Axcelis describes itself as a leading supplier of enabling ion implantation solutions for the semiconductor industry, with more than 45 years of experience providing high-productivity systems and lifecycle support.
Investors and industry followers can use this page to monitor Axcelis’ updates on product launches, technology platforms and market engagement. Recent news has highlighted the introduction of the Purion Power Series+ ion implant platform for next generation power devices, including silicon carbide (SiC) power devices and superjunction architectures, as well as the GSD Ovation ES high current implanter for engineered substrates. Company releases also cover its participation in major industry events such as SEMICON Japan and the International Conference on Silicon Carbide and Related Materials (ICSCRM), where Axcelis technologists present technical work on SiC and related materials.
The feed also includes financial and corporate developments, such as quarterly results announcements, conference call schedules and Axcelis’ participation in investor conferences. A significant recent development is the all-stock merger agreement with Veeco Instruments Inc., under which Veeco is expected to become a wholly owned subsidiary of Axcelis, subject to regulatory and shareholder approvals.
By following this ACLS news page, readers can track Axcelis’ communications on its ion implantation product portfolio, aftermarket strategy, global customer engagement and planned combination with Veeco, all drawn from official press releases and SEC-referenced materials.
Axcelis Technologies (NASDAQ: ACLS), a leading provider of ion implantation solutions for the semiconductor industry, has announced its participation in three upcoming investor conferences in September 2025.
The company will attend the Benchmark Tech, Media & Telecom Conference on September 4th at the New York Athletic Club, the Citi Global TMT Conference on September 5th at the New York Hilton Midtown, and the B. Riley Securities Consumer & TMT Conference on September 10th at the Sofitel, New York.
Axcelis Technologies (Nasdaq: ACLS) has announced a strategic Joint Development Program (JDP) with GE Aerospace to develop production-worthy 6.5 to 10kV superjunction power devices. The collaboration will utilize Axcelis' Purion XEmax™ high energy implanter, which offers the industry's highest beam currents up to 15MeV.
The partnership is part of the Commercial Leap Ahead for Wide Bandgap Semiconductors (CLAWS) Hub project led by North Carolina State University. The initiative focuses on developing Silicon Carbide (SiC) wide bandgap semiconductors, which offer superior performance in voltage, operating temperatures, and frequencies compared to traditional Silicon devices. These advanced semiconductors are crucial for aerospace, defense, AI, quantum computing, autonomous vehicles, and power grid applications.
Axcelis Technologies (NASDAQ: ACLS) reported its Q2 2025 financial results with revenue of $194.5 million, showing resilience despite market challenges. The company achieved a GAAP gross margin of 44.9% and non-GAAP gross margin of 45.2%, with GAAP diluted EPS of $0.98 and non-GAAP EPS of $1.13.
Notable highlights include increased share repurchase activity of $45 million during the quarter and strong profitability despite cyclical market digestion. For Q3 2025, Axcelis projects revenues of approximately $200 million with GAAP EPS of $0.87 and non-GAAP EPS of $1.00.
Axcelis Technologies (NASDAQ: ACLS), a leading provider of ion implantation solutions for the semiconductor industry, has announced its participation in three upcoming investor conferences in August 2025:
- KBCM Technology Leadership Forum - August 11th at Montage Deer Valley, Park City, UT
- Jefferies Semiconductor, IT Hardware and Communications Technology Conference - August 26th at Four Seasons Hotel, Chicago, IL
- Evercore ISI 2025 Semiconductor Conference - August 27th at Omni Chicago, IL
Axcelis Technologies (Nasdaq: ACLS), a leading semiconductor ion implantation solutions provider, has scheduled its Q2 2025 earnings release and conference call. The financial results will be released before market open on Tuesday, August 5, 2025, followed by a conference call at 8:30 a.m. ET the same day.
Investors can access the webcast through Axcelis' website investor section or by registering directly through the provided link. The webcast replay will remain available for 30 days after the call.
Axcelis Technologies (NASDAQ: ACLS), a leading ion implantation solutions provider for the semiconductor industry, has announced its participation in eight major investor conferences between May and June 2025. The company will attend prestigious events including the J.P. Morgan Global Technology Conference, B. Riley Investor Conference, TD Cowen Technology Conference, Stifel Cross Sector Conference, William Blair Growth Stock Conference, Bank of America Global Technology Conference, and DA Davidson Consumer & Technology Conference.
At the William Blair conference, management will conduct a Fireside Chat at 2:00 PM Central Time on June 4th, which will be publicly accessible via webcast through Axcelis' website.
Axcelis Technologies (NASDAQ: ACLS) announced its sponsorship and participation in the Advanced Semiconductor Manufacturing Conference (ASMC) scheduled for May 5-8, 2025, in Albany, New York. The company will present research on particle control for low-energy boron implantation in Session 5: Contamination Free Manufacturing.
Dr. Phillip Geissbuhler, Staff Scientist at Axcelis, will present findings from a collaborative study with SK Hynix on May 6, 2025. The presentation focuses on new hardware implementation that reduces particle contamination during low-energy boron implants by increasing ion beam angles to enhance self-sputtering of films. This innovation significantly reduces film buildup on surfaces near implanted wafers, addressing a critical yield-impacting issue in semiconductor manufacturing.
Axcelis Technologies (NASDAQ: ACLS) has issued a correction to their previous press release regarding their participation in the Advanced Semiconductor Manufacturing Conference (ASMC). The correction pertains to two coauthor names: Charlie Free (previously listed as David Free) and DaeYoon Kim (previously listed as Dae Yun Kim).
The company will sponsor ASMC, scheduled for May 5-8, 2025, at the Hilton Albany, New York. During Session 5: Contamination Free Manufacturing on May 6, Dr. Phillip Geissbuhler will present research on 'Particle Control for Low-Energy Boron Implantation' at 3:40 PM.
The presentation details a case study on reducing particle contamination during low-energy boron implants through new hardware implementation. The innovation increases ion beam angle to enhance self-sputtering of films, significantly reducing film buildup on surfaces near implanted wafers, thereby improving device yields.
Axcelis Technologies (Nasdaq: ACLS), a leading ion implantation solutions provider for the semiconductor industry, has scheduled its first quarter 2025 financial results announcement. The company will release its Q1 2025 results before market opening on Tuesday, May 6, 2025, followed by a conference call at 8:30 a.m. ET the same day.
Investors can access the earnings call via webcast through Axcelis' website investor section or by registering directly as participants. The webcast replay will remain available for 30 days after the call.